Skip to main content

Table 1 Overview of the Quality of Life Special Study module sessions and associated learning outcomes

From: The need for education on health related-quality of life

Session Key Learning outcomes
1. What is QoL and why might we wish to assess it? • Provide definitions of the terms quality of life and health-related quality of life.
  • Identify situations when the assessment of QoL may be appropriate and provide the rationale for such an assessment.
2. How can we measure QoL? • Identify the key features of generic and disease specific instruments and the advantages/disadvantages of such measures.
3. Methodological considerations for the assessment of QoL in a clinical trial. • Discuss how to choose an appropriate instrument(s) to assess the QoL of patients with a particular disease.
  • Describe methodological issues that should be considered when assessing QoL in a clinical trial.
4. Assessing the reporting of QoL in clinical trials • Be able to evaluate the reporting of QoL in clinical trials.
5. Use and assessment of QoL in routine clinical practice • Explain the potential advantages and disadvantages of routine QoL assessment.
6. How is QoL used in licensing/policy making? • Identify key issues that need to be addressed for QoL to be considered as a credible criterion in the drug regulatory process.
  • Understand the different methods that are used for eliciting patient preferences.
  • Define and perform simple calculations of quality adjusted life years and understand their use in cost-utility analysis.